Equities
Health CareMedical Equipment and Services
  • Price (USD)38.76
  • Today's Change-0.61 / -1.55%
  • Shares traded3.34m
  • 1 Year change-0.51%
  • Beta0.5861
Data delayed at least 15 minutes, as of Sep 19 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Baxter International Inc has grown net income from a loss of 2.43bn to a gain of 2.66bn despite relatively flat revenues (from 14.51bn to 14.81bn).
Gross margin36.48%
Net profit margin-0.99%
Operating margin1.62%
Return on assets-0.55%
Return on equity-2.38%
Return on investment-0.70%
More ▼

Cash flow in USDView more

In 2023, Baxter International Inc increased its cash reserves by 85.71%, or 1.48bn. Cash Flow from Investing totalled 3.21bn, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 1.73bn in cash from operations while cash used for financing totalled 3.49bn.
Cash flow per share2.18
Price/Cash flow per share18.10
Book value per share14.98
Tangible book value per share-8.04
More ▼

Balance sheet in USDView more

Baxter International Inc has a Debt to Total Capital ratio of 62.60%, a lower figure than the previous year's 256.89%.
Current ratio1.40
Quick ratio0.9147
Total debt/total equity1.69
Total debt/total capital0.626
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 97.16% while dividends per share growth only marginally increased 0.87%. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)1.75%
Div growth rate (5 year)9.71%
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
94.93
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.